|
Ken Stuart , Ph.D.
Mission
The Stuart lab studies complex single-celled organisms that cause a staggering amount of human and animal disease worldwide. The research is
designed to develop understanding of fundamental molecular processes in these organisms in order to identify targets for new drugs and discover components of these parasites that can be developed into vaccines and diagnostic tools.
Research
The Stuart lab is focused on Trypanosomatid pathogens:
Trypanosoma brucei, Trypanosoma cruzi, and
Leishmania species. One major focus is on the process of, the molecular machinery for, and the physiological significance of RNA editing,
and the potential for developing drugs
directed at this process or its
physiological role.
Dr. Stuart determined the general mechanism of editing, identified many components of the editosome
and the functions and interactions of many of
these components. His lab is exploring editosome functional structure, steps in the editing process,
and effects on parasite physiology upon disruption of editing.
A second focus of the Stuart
lab is functional genomics. He led the formation
of international genome projects that sequenced
and compared Trypanosome and Leishmania genomes
in close collaboration with
Peter Myler, Ph.D. His current
projects are building on these
sequencing efforts and include a mitochondrial
proteomic project that is designed to identify
the functions of all proteins in this organelle
for the purpose of developing drugs that are
needed for several diseases caused by this group
of pathogens.
Much of
the support for Dr. Stuart’s research is provided by the National Institutes of Health (NIH).
|